This is a slide prepared by urology resident.
It's an approach and management principles of priapism and peyronie's disease.
I hope it is useful for who reads it.
Leave me a comment
❤️Chandigarh Escorts Service☎️9814379184☎️ Call Girl service in Chandigarh☎️ ...
priapism and peyronies disease.pptx
1. Pathology, Diagnosis, Management
of Priapism and Peyronies disease
Prepared by : Dr. Ibsa Daba(Urology Resident)
Addis Ababa Univeristy,Ethiopia
1
Priapism and Peyronies disease(Ibsa.D)
3. Defining Priapism
• Priapism is a full or partial erection that continues more than 4 hours beyond
sexual stimulation and orgasm or is unrelated to sexual stimulation.
Classification
• 1.Ischemic priapism
• 2.Non ischemic priapism
• 3.Stuttering priapism
3
Priapism and Peyronies disease(Ibsa.D)
4. Classification
• Ischemic priapism (Veno-occlusive, Low flow)
Is a persistent erection marked by rigidity of the corpora cavernosa (CC)
There is little or no cavernous arterial inflow
Analogous to compartment syndrome
• Non ischemic priapism (Arterial, High flow)
Is a persistent erection caused by unregulated cavernous arterial inflow
Typically, the corpora are tumescent but not rigid and the penis is not painful
• Stuttering priapism
Is characterized by a pattern of recurrence
Recurrent unwanted and painful erections in men with SCD,
Can last for several hrs with intervening periods of detumescence 4
Priapism and Peyronies disease(Ibsa.D)
5. 1. Etiology of Ischemic priapism
• Sexual stimulation or the administration of pharmacologic agents
• Hematologic dyscrasias are a major risk factor for ischemic priapism
• Priapism may occur in patients with excessive WBC counts(leukemia) malignant infilatration of penis
• Priapism secondary to metastatic infiltrating solid lesions is rare( peripheral nerve sheath tumor)
• Iatrogenic -Medications/Injections
• Intracavernous injection
• Oral Phosphodiesterase Type 5 Inhibitors,
• Medications for Attention-Deficit/ Hyperactivity Disorder,
5
Priapism and Peyronies disease(Ibsa.D)
6. 2.Etiology of Stuttering priapism
• Patients with SCD may experience stuttering priapism from childhood
• Commonly reported precipitants of full-blown SCD priapism are;
• Stuttering nocturnal or early morning erections, dehydration, fever, and exposure to cold
• Sleep-related erections (SREs) take place during REM sleep
6
Priapism and Peyronies disease(Ibsa.D)
7. 3.Etiology of Nonischemic (Arterial, High-Flow) Priapism
• Due to Damaged artery or arteriole ruptures;
• the unregulated arterial inflow creates a arteriole-lacunar fistula
• The cause most commonly reported is a straddle injury to the crura.
• Other mechanisms
• include coital trauma,
• kicks to the penis or perineum,
• Pelvic fractures,
• birth canal trauma to the newborn male,
• needle lacerations,
• complications of penile diagnostics, and
• vascular erosions complicating metastatic infiltration of the corpor
• HFP has been described after iatrogenic injury from cold-knife urethrotomy , Nesbitt corporoplasty,
and deep dorsal vein arterialization
Priapism and Peyronies disease(Ibsa.D) 7
8. EVALUATION AND DIAGNOSIS OF PRIAPISM
Determine whether the underlying priapism
hemodynamics are ischemic or
nonischemic
• Non ischemic priapism
• no pain and
• the erection duration has not been accompanied by
progressive discomfort.
• Perineal trauma
• Chronic flaccidity
Priapism and Peyronies disease(Ibsa.D) 8
• Ischemia should be suspected
• progressive penile pain
• associated with the duration of erection;
• drug associated with priapism;
• Has SCD or another blood dyscrasia; or
• known neurologic condition, especially those
affecting the spinal cord
10. Elements in Taking the History of Priapism
• Duration of erection(exam: rigid erection vs tumescense)
• Presence of pain
• Inciting event
• Persistent morning erection
• Pharmacologic erection
• Trauma to pelvis , perineum or penis
• Previous episodes of priapism
• Medications and recreational drugs
• Sickle cell disease(hemoglobinopathies, hypercoaguble staes
• Baseline erectile function
• Presence and duration of morning erection
• Use of PDE 5 inhibitors
10
Priapism and Peyronies disease(Ibsa.D)
11. Physical Examination
• Inspection and palpation of the penis
• In ischemic priapism
• the corporal bodies will be completely rigid; and tender
• the glans penis and corpus spongiosum are not.
• non ischemic priapism should be suspected.
• nontender,
• tumescent,
• partially erect,
• Although malignancies rarely cause priapism,
• examination of the abdomen, testicles, perineum, rectum, and prostate may help identify a primary cancer.
• Malignant infiltration of the penis causes indurated nodules within or replacing corporal tissue.
11
Priapism and Peyronies disease(Ibsa.D)
12. Laboratory Testing
• Complete blood count (CBC)
• WBC count with blood cell differential,
• Platelet count
• Coagulation profile
• In African-Americans, a sickle cell screening should be requested
• hemoglobin electrophoresis,
• reticulocyte count,
• lactate dehydrogenase)
• Urine and serum toxicology
12
Priapism and Peyronies disease(Ibsa.D)
13. Corporal blood aspiration
• The corporal blood aspirate differentiates
ischemic from nonischemic priapism.
• Aspirate -send -Blood gas analysis sent
• Aspirate- inspect the blood
13
Priapism and Peyronies disease(Ibsa.D)
14. Penile Imaging
CDU (color Doppler ultrasound
is an adjunct to the corporal aspirate in
differentiating ischemic from non
ischemic priapism.
• prolonged ischemic priapism
• no blood flow in the cavernous
arteries.
• non ischemic priapism have
• normal to high blood flow
velocities detectable in the cavernous
arteries;
MRI in priapism
Three possible roles for MRI to help in the
assessment of priapism;
1. Imaging of a well-established arteriolar-
sinusoidal fistula
2.Ischemic priapism to demonstrate the
presence and extent of tissue thrombus and
corporal smooth muscle infarction
3. Imaging the penis for corporal malignancy
or metastasis.
Priapism and Peyronies disease(Ibsa.D) 14
16. MEDICAL TREATMENTS
Ischemic Priapism
• Oral agents are not recommended in the management of acute
ischemic priapism (>4 hours)
• The recommended initial treatment is the decompressin of the
by aspiration
• Phenylephrine (200 µg) injected with an ultrafine needle and 1-
mL syringe may reverse the erection
• Followed by α-adrenergic injection or irrigation
16
Priapism and Peyronies disease(Ibsa.D)
17. SCD and hematologic malignancies
• Classically, treatment of SCD-induced ischemic priapism involved
• analgesics,
• hydration,
• oxygen,
• bicarbonate, and
• exchange transfusion.
• Unfortunately, acute neurologic complications may follow exchange transfusions.
• Reports from hematology centers suggest high success rates with use of
• Penile aspiration and injection
• Irrigation with intracavernous sympathomimetics
• SCD priapism
17
Priapism and Peyronies disease(Ibsa.D)
18. Surgical management
• Surgical management of ischemic priapism is indicated
• After repeated penile aspirations and injections of sympathomimetics have failed
• If such an attempt has resulted in a significant cardiovascular side effect.
• Timing of surgical intervention
• 2004 International Consultation on Sexual Medicine in Paris recommended
• corporal aspiration and α-adrenergic agonists for at least
• 1 hour before consideration of shunting
• Early surgical intervention may be preferable in
• patients with malignant or poorly controlled hypertension or
• for men who are using monoamine oxidase inhibitor medications contraindicating α-adrenergic therapies.
18
Priapism and Peyronies disease(Ibsa.D)
19. Shunting
• Percutaneous distal shunts
• Ebbehoj, Winter, or, T shunt
• Open distal shunt
• Al-Ghorab or Corporal snake
• Open proximal shunt
• Quackles or Sacher
• Saphenous vein
• Grayhack
• Deep dorsal vein shunt
• Barry
19
• The objective of shunt surgery is
reoxygenation of the cavernous smooth
muscle.
• The shared principle of shunt procedures is
to reestablish corporal inflow by relieving
venous outflow obstruction;
• creation of a fistula between the
• CC and glans penis,
• CC and corpus spongiosum, or
• CC and dorsal or saphenous veins.
Priapism and Peyronies disease(Ibsa.D)
20. 1.T shunts (Percutaneous distal shunts )
• In T shunting a No. 10 blade is placed vertically through
the glans 4 mm away from the meatus;
• the blade pierces through the glans to the CC and is
rotated 90 degrees away from the urethra and removed
• Deoxygenated blood is milked out of the wound.
• The Al-Ghorab shunt requires the excision of
circular cone segments of the distal tunica
albuginea (5 × 5 mm)
• 2-cm transverse incision is made on the glans;
the distal tips of the rigid CC are incised and
grasped with 2-0 stay sutures or Kocher clamps.
20
2. Open distal shunt—Al-Ghorab
Priapism and Peyronies disease(Ibsa.D)
22. 3 Proximal shunt
• Proximal corpus cavernosum to
corpus spongiosum (CC-CS) shunt
procedures require a trans-scrotal or
transperineal approach .
22
4.Saphenous vein bypass or deep
dorsal vein shunt
Priapism and Peyronies disease(Ibsa.D)
23. Non-ischemic priapism management
• Arterial priapism is not an emergency.
• Spontaneous resolution or response to
conservative therapy has been reported in
up to 62% of published series
• The pathognomonic arteriographic finding
is an arteriolacunar fistula.
• Selective internal pudendal catheterization
and subsequent embolization have been
reported with various agents: microcoils ,
polyvinyl alcohol, N-butylcyanoacrylate, gel-
foam, and autologous blood clot.
• Surgical management with direct ligation of
fistula as a last resort
23
Priapism and Peyronies disease(Ibsa.D)
24. Embolization
• The success rates with selective pudendal
artery catheterization followed by
embolization are high (89% to 100%),
regardless of the embolization material
used
24
Priapism and Peyronies disease(Ibsa.D)
26. Introduction
• PD is currently recognized as a wound-healing disorder of t
he tunica albuginea
• An injury to the penis activates an abnormal wound-healing
response
• The resulting scar or plaque is inelastic and therefore res
ults in penile deformity
26
Priapism and Peyronies disease(Ibsa.D)
27. NATURAL HISTORY
• There are two phases
• 1. Active (acute) phase,
• painful erections and
• changing deformity of the penis.
• 2.Stable (chronic) phase,
• stabilization of the deformity and
• disappearance of painful erections
27
Priapism and Peyronies disease(Ibsa.D)
28. Misconceptions
• 1.These include that PD is a rare disorder.
• In contrary the prevalence of PD is somewhere between 3% and 20%, and
• Higher DM and ED
• 2.PD has a reasonable likelihood of resolving spontaneously
• Full spontaneous resolution extremely rare
• If no treatment is offered it gets worsen
• 3. PD is a disorder that occurs only in middle-aged men.
• Multiple studies have demonstrated that it can occur in teenagers to men in their late 70s
28
Priapism and Peyronies disease(Ibsa.D)
30. PENILE ANATOMY AND PEYRONIE’S DISEASE
• The tunica albuginea
• oriented with an
• inner circular and
• outer longitudinal layer
• Functions include: structural support ,protection , part of veno-occlusive
mechanism
• The longitudinal layer of the tunica albuginea is
• thinnest at the 3 and 9 o’clock positions of the corpora;
• it is completely absent between the 5 and 7 o’clock positions
• Greater ease of dorsal buckling
• 60% to 70% of plaques are located on the dorsal aspect of the penis
30
Priapism and Peyronies disease(Ibsa.D)
31. Etiology
• Exact cause not yet defined
• Connective tissue disorders-duputyeran contracture
• Antecedent trauma has been reported in 16% to 40% of patients
• The proposed mechanism is that in the erect state,
• the pressures inside the penis can get quite high and
• acutely higher when external forces are placed on the penis during intercourse in particular.
• During sexual intercourse….
• sexual positioning,partner on the top
• Trauma to the flaccid penis may also trigger this process
31
Priapism and Peyronies disease(Ibsa.D)
32. Impact of wound healing in peyronies disease
• Remodeling phase in wound healing in the normal situation may last up to 1 or 2
years.
• The remodeling of an acute wound is tightly regulated by mechanisms that balance
the simultaneous degradation and synthesis of collagen and other ECM
macromolecules.
• Any alterations in this process may lead to abnormal wound healing
with excessive scarring
Priapism and Peyronies disease(Ibsa.D) 32
33. Clinical presentation
• Common presenting symptoms
Penile pain
Erect Deformity
Palpable plaque
ED
torque pain
• Associated with pulling sensation of strong
erection
33
History
Onset was gradual or sudden
Estimated time that symptoms began;
Inciting event
Direct external penile trauma to the flaccid or erect penis
Instrumentation
Personal or family history of other fibrotic disorders
including DD and Ledderhose
Priapism and Peyronies disease(Ibsa.D)
34. PD questionnaire (PDQ)-15 components
• (1) Peyronie’s psychological and physical symptoms (six items),
• (2) penile pain (three items), an
• (3) the effects of PD symptoms (six items)
35. Physical examination
• Kelami ( 1983 classification)
• 30 degree or less ---mild(39%)
• 31-60 degree---moderate(35%)
• >60---severe (13%)
• 12% had no curvature but did experience hourglass deformity
• Measurement by goniometer
• Photograph at home during erect form lateral and antero posterior
• Stretched penile length (SPL) is also a critical parameter to measure at
the initial consultation
• PD plaque can manifest in a variety of configurations including
• Cords;
• Simple nodules;
• Coinlike
• Irregular dumbbell shapes; or
• I-beam plaques
35
Priapism and Peyronies disease(Ibsa.D)
36. Role of duplex ultrasound
• Identification of calcification during initial surveillance
in the flaccid state,
• Assessment of penile vascular flow parameters
after intracavernosal injection of vasoactive agent,
• Observation of the erectile response to the vasoactive injection
compared with the patient’s sexually induced erection at home.
• Provision of the best opportunity to objectively assess deformity
36
Priapism and Peyronies disease(Ibsa.D)
37. Management
• Reassurance- if there is no difficulty or pain for the patient or his partner in accomplishing
penetrative sex.
• Oral agents
Potaba, Vit E,Tamoxifen, Colchicine,- not recommended in AUA 2015,no benefit in reduction of plaque
Pentoxyflline,-
PDE5I-not recommended for PD
Priapism and Peyronies disease(Ibsa.D) 37
38. Intralesional – recommended in AUA 2015
• Verapamil
Predictors of success-
• younger age
• Curvature > 30 degree
Poor candidates
• Extensive calcification
• Curvature >90 degree
• Ventral curvature
• Nicardipine – not recommended in AUA 2015
• IFN alpha- recommended, minor side effects
• Clostridial collagenase
• Combination therapy
• Intralesional + oral agents +
traction therapy
• Intralesional + oral agents
38
Priapism and Peyronies disease(Ibsa.D)
39. External force application
1. Electromotive : Verapamil +/- Dexamethasone-
2.ESWT
1. Direct damage to the penile plaque
2. Increases vascularity, induction of inflammatory rxn,
lysis of plaque potential benefit of ESWT with regard to pain reduction,
3.Penile traction –Traction therapy has the potential to be an effective nonsurgical treatment,
to recover lost length, reduce curvature, and enhance girth.
4.vacuum therapy-
5.Radiation therapy-
39
Priapism and Peyronies disease(Ibsa.D)
41. Choice of surgery
• The primary determinants for the choice of surgical approach are based on two factors, including
• quality of the preoperative erection hardness and
• Severity of deformity, including curvature and indentation.
• In men who have rigidity that is adequate for coital activity with or without pharmacotherapy,
• tunica plication techniques and
• plaque incision or
• partial excision with grafting may be used
• Grafting procedures are recommended for those
• with more complex curves of greater than 60 to 70 degrees
• and/or a destabilizing hourglass resulting in a hinge effect
• PD and ED that is refractory to medical therapy,
• published algorithms have indicated that penile prosthesis placement is the procedure of choice
41
Priapism and Peyronies disease(Ibsa.D)
42. Surgical options( tunica shortening Procedures)
42
Nesbit procedure Yachia procedure
TAP Dot Procedure
A, The Nesbit procedure employs a transverse elliptical
incision of the tunica albuginea. B, This is done contralateral to the
area of greatest curvature. C, The defect is closed transversely with
permanent suture with or without the addition of absorbable suture.
The Yachia procedure employs a full-thickness vertical
incision (B) in the tunica albuginea contralateral to the area of
greatest curvature and is closed transversely (C) without removal of
tunica albuginea.
The dot procedure employs no incision. The tunica albuginea is plicated with
permanent suture using an extended Lembert-type suture placement
followingfour dots per plication. A, Suture placement for dorsal curve. B, Suture
placement for ventral curve.
tunica albuginea plication (TAP) procedure (A) employs a pair of
transverse parallel incisions (B) separated by 0.5 to 1.0 cm. The
incision is made through the longitudinal fibers but does not violate
the inner circular fibers of the tunic. C, The longitudinal fibers
between the two transverse incisions are removed to reduce the bulk
Priapism and Peyronies disease(Ibsa.D)
43. Tunica lengthening procedures
• Plaque incision and grafting (PIG) or partial plaque excision and
grafting (PEG)
• Greater complexity of disease
• Curvature > 60-70 degrees
• Shaft narrowing , hinging
• Extensive plaque calcification
• Strong pre-op erection is mandatory
• when he is asked directly, “If your penis was straight, would the
quality of rigidity that you currently have allow penetrative sex?”
43
Priapism and Peyronies disease(Ibsa.D)
44. Penile prosthesis
• Penile prosthesis
• In men with PD and concurrent ED refractory to PDE5 inhibitors
• ED +/- penile deformity sufficient to impair coitus
Priapism and Peyronies disease(Ibsa.D) 44
Prolonged erection is more commonly reported than
priapism after therapeutic or diagnostic injection of
intracavernous vasoactive medications.
• In worldwide clinical trials of alprostadil, prolonged
erection (defined as 4 to 6 hours) occurred in 5% of
administrations, and priapism (longer than 6 hours) in 1%.
• In clinical practice, ICI of Trimix (papaverine,
phentolamine, and alprostadil) results in prolonged
erections in 5% to 35% of administrations.
• Few case reports have documented priapism after PDE5
inhibitor therapy. These reports suggest that men were at
increased risk for priapism because of SCD, spinal cord
injury, use of a PDE5 inhibitor recreationally, use of a
PDE5 inhibitor in combination with ICI, history of penile
trauma, use of psychotropic medications, or abuse of
narcotics.
• Methylphenidate medications and atomoxetine used in the
treatment of ADHD may result in prolonged erection or
priapism.
It is believed that the hemodynamics of a nocturnal erection disrupts the clot and the damaged artery or arteriole ruptures; the unregulated arterial inflow creates a arteriole-lacunar fistula
In nonischemicpriapism the corpora will be tumescent but not completely rigid.In children and adults with HFP, depending on the location of traumaand time since the traumatic event, there may be residual bruisingat the perineum from straddle injury
hematologic abnormalities may cause priapism,including leukemia, platelet abnormalities, and thalassemia, andthese should be sought if the cause is not evident. An elevatedreticulocyte count is nonspecific and may be present in priapismcaused by SCD and in thalassemia.
Aspiration may be diagnostic and therapeutic.
deoxygenated blood with a“crankcase oil” appearance in ischemic priapism.
The differential diagnosis includes
resolved ischemia with penile edema,
persistent ischemia, and
conversion to high-flow state
vasoactive injection results in a prolonged erection with duration longer than 1 hour but shorter than 4 hours, aspiration may not be necessary.
Phenylephrine (200 µg) injected with an ultrafine needle and 1-mL syringe may reverse the erection.
Reversing a prolonged erection will spare the patient and the office staff the complexity of treating full-blown ischemic priapism
Extremes of age (children vs. elderly), home dosing with pseudoephedrine, and preexisting cardiovascular diseases should be taken into consideration before intracavernoussympathomimetic administration.
Serial monitoring of blood pressure and pulse should be performed during and immediately after ICI of sympathomimetic drugs.
Potential side effects of intracavernous sympathomimetics include headache, dizziness, hypertension, reflex bradycardia, tachycardia, and irregular cardiac rhythms
Hematologists have begun toquestion the emphasis on intravenous hydration, sodium bicarbonatefor alkalinization, and exchange transfusion as first-line therapy forSCD-associated priapism
Hydroxycarbamide (hydroxyurea) is a hematologic agent used in the management of vaso-occlusivecrises in sickle cell patients (Morrison and Burnett, 2012; Saad et al.,2004). The proposed mechanisms of action are increase in productionof hemoglobin F; reduction of leukocytes, platelets, and reticulocytes;and promotion of release of NO
Inthe creation of a T shunt the No. 10 blade is rotated (90 degrees away from the urethra) after insertion andis then withdrawn. In both the percutaneous techniques deoxygenated blood is milked out of the openwounds; once bright red blood is seen, the skin is closed, leaving the deeper incision of the open surgicalfistula. In either procedure the maneuver may be repeated on the opposite corpus
Deoxygenated blood is milked out of the CC, but rather than excising a wedge of tunica and underlying CC muscle, a 7/8 Hegar dilator is advanced through each of the tunica windows proximally several centimeters to release blood and thrombus.
Although ultimately successful, embolization of HFP may requireretreatment. The most notable side effect of bilateral arterialembolization is ED. Recurrence of HPF after embolization maybe caused by recanalization of the embolized fistula or unmaskingof a fistula in the contralateral cavernous artery.
The surgical approach is transcorporal .
Intraoperative Doppler ultrasound guidance is recommended
Patients who do not wish to pursue expectant management
Poor candidates for angioembolization
Reserved for patients who refuse the procedure;
Patients in places where technology is not available; and
Patients in whom angioembolization has failed
1.These include that PD is a rare disorder.
On the contrary, we now know that the prevalenceof PD is somewhere between 3% and 20%, and
in certain populations such as those with diabetes mellitus and ED the prevalence may be even higher
2.PD has a reasonable likelihood of resolving spontaneously
We now know from multiple natural history studiesthat full spontaneous resolution is extremely rare and that it ismore likely that within the first 12 to 18 months after presentation,if no treatment is offered, up to 50% of patients will experienceworsening of their deformity
3. PD is a disorder that occurs only in middle-aged men.
Multiple studies have demonstrated that it can occur in teenagers to men in their late 70s
1.These include that PD is a rare disorder.
On the contrary, we now know that the prevalenceof PD is somewhere between 3% and 20%, and
in certain populations such as those with diabetes mellitus and ED the prevalence may be even higher
2.PD has a reasonable likelihood of resolving spontaneously
We now know from multiple natural history studiesthat full spontaneous resolution is extremely rare and that it ismore likely that within the first 12 to 18 months after presentation,if no treatment is offered, up to 50% of patients will experienceworsening of their deformity
3. PD is a disorder that occurs only in middle-aged men.
Multiple studies have demonstrated that it can occur in teenagers to men in their late 70s
Tunica albuginea across the corpora cavernosa are reinforced by pillars
2 to 6 o’clock and
10 to 6 o’clock positions, with
finer pillars at the 5 and 7 o’clock positions
When expansion is limited at one point along the circumference of the corpora by the inelastic scar of the Peyronie’s plaque,
deviation to that side occurs; a circumferential plaque may lead to an hourglass deformi
Matrix metalloproteinases (MMPs) (collagenases), produced by neutrophils, macrophages, and fibroblasts in the wound, are responsible for the degradation of collagen.
They are subsequently held in check by inhibitory factorscalled tissue inhibitors of metalloproteinases (TIMPs)
This balance between TIMPs and MMPs has also been studied in the pathogenesis of PD and is described later in this section.
men are capable of sexual activity with curvature up to 60 degrees, particularly if the curvature is dorsal and more gradual along the shaft
Men with ventral orlateral curvatures may have a more difficult time with intromission
Some patients require only reassurance, particularly if there isno difficulty or pain for the patient or his partner in accomplishingpenetrative sex. Patients should also be reassured that this is not adisorder that will degenerate into a cancer and is therefore notlife-threatening
Potassium paraaminobenzoate appears to be
useful to stabilize the disorder and prevent progression of penile
curvature” (Weidner et al., 2005). No severe adverse events occurred
in the study; however, acute hepatitis associated with administration of potassium para-aminobenzoate for PD has been reported
(Roy and Carrier, 2008). Because there is little evidence of benefit
with potassium para-aminobenzoate in placebo-controlled trials
and it is expensive and difficult to consume (24 tablets daily), the
AUA 2015 PD guideline does not recommend its use
Treatment with vitamin E inactivates circulating free radicals that
otherwise would inhibit NO from exerting its positive effects on
vascular smooth muscle (Safarinejad et al., 2007).
Several well-designed studies have demonstrated no significant
improvement in pain, curvature, and plaque size when compared
with placebo
Pentoxifylline has been shown to block the TGF-β1–mediated
pathway of inflammation and to prevent deposition of collagen
type I and is a nonspecific phosphodiesterase inhibitor with
combined anti-inflammatory and antifibrogenic properties.
Improvement in penile curvature and plaque volume
was significantly greater in patients treated with pentoxifylline
than with placebo. The increase in International Index of Erectile
Function (IIEF) total score was significantly higher in the pentoxifylline group. One patient discontinued the medication because of
adverse effects. There were no adverse effects in any of the vital signs
or in the laboratory data. Pentoxifylline is a peripheral vasodilator
and could induce hypotension; consequently, blood pressure should
be monitored during treatment with this drug. The most common
side effects include nausea, vomiting, dyspepsia, malaise, flushing,
dizziness, and headache
PDE5 inhibitors have also been suggested as treatment for PD.
By increasing the levels of cGMP, PDE5 inhibitors can inhibit collagen synthesis and induce fibroblast and myofibroblast apoptosis,
thus acting as antifibrotic agents by inhibiting scar development
(Gonzalez-Cadavid and Rajfer, 2010; Valente et al., 2003).
In a study by Chung et al., (2011b), 35 men with an isolated
septal scar received tadalafil 2.5 mg daily over a 6-month period,
after which 24 patients (69%) had resolution of the septal scar.
The authors concluded that low-dose daily tadalafil is a safe and
effective treatment option in septal scar remodeling (Chung et al.,
2011a). Although oral PDE5 inhibitors are recommended for the
treatment of male erectile dysfunction, they are not recommended
for the treatment of Peyronie’s disease
injection was introduced in 1957 (Furey, 1957; Levine et al.,
1994). This was a nonrandomized dose-escalating study in 14 men
who received biweekly injections of verapamil for 6 months. Subjectively, there was significant improvement in plaque-associated
penile narrowing (100%) and curvature (42%). Objectively, a
decreased plaque volume of more than 50% was noted in 30% of
the subjects.
Intralesional
The first US Food and Drug Administration (FDA)–approved drug
for the treatment of PD, collagenase Clostridium histolyticum (CCH),
is produced by the bacterium C. histolyticum and selectively degrades
collagen types I and III in connective tissues despite the presence
of TIMPs, which have been shown to be elevated in PD and to
increase apoptosis of fibroblasts
Transdermal drug delivery was proposed to be superior to oralor injection therapy because it bypasses hepatic metabolism andminimizes the pain of injection. Unlike topical verapamil gel,electromotive drug administration (EMDA) with verapamil has beenfound to deliver detectable levels of the drug to the tunica albuginea
Tunica plication techniques
are recommended for those who have a simple curvature
of less than 70 degrees, those with absence of an hourglass or
hinge effect, and those in whom the anticipated loss of length
would be less than 20% of the total erect length
Penile plication aims to shorten the longer (or convex) side of
the tunica albuginea to match the length to the shorter side (Syed
et al, 2003; Ralph, 2006). Advantages to these approaches include
shorter surgical time, good cosmetic outcomes, minimal effect
on rigidity, simple and safe surgery, and effective straightening
(Hudak et al, 2013; Hatzimouratidis et al, 2012). Disadvantages
include shortening and failure to correct an hourglass or hinge.
This technique uses excision of an elliptical segment of the tunica
on the contralateral side of the curvature. In the setting of a ventral
curvature, once Buck’s fascia has been elevated, small wedges of
the dorsal tunica albuginea are excised and then the defect is closed,
typically with permanent suture. Multiple variations on this
approach have evolved, including the Yachia procedure, which uses
the Heineke-Mikulicz technique
The most recent International Consultation on Sexual Medicine
(ICSM) published recommendations regarding plication procedures
in 2010 and reported that there was “no evidence that one
surgical approach provides better outcomes over another, but
curvature correction can be expected with less risk of new ED”
when compared with grafting procedures
The drawbacks of any tunica plication procedure for PD are
that it does not correct shortening and it potentially may enhance
loss of penile shaft length. It does not address hinge or hourglass
effect and may exacerbate it, resulting in an unstable penis. The
plaque is also left in situ. Penile narrowing or indentation has
been reported in up to 17% with these techniques. In addition,
there can be pain associated with the knots and suture granulomas
(Tornehl and Carson, 2004; Taylor and Levine, 2008; Ralph et al,
It appears
intuitive that to reduce the risk of postoperative ED, the key is
to limit the trauma to the underlying cavernosal tissue to maintain
the veno-occlusive relationship between the cavernosal
tissue and the overlying tunica graft.